Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepatitis C
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepatitis C
    TopAbstracts in Hepatitis C 02/02/2010 - (DGNews)
    TopAbstracts in Hepatitis C 01/19/2010 - (DGNews)
    TopAbstracts in Hepatitis C 01/05/2010 - (DGNews)
    Liver Stiffness Measurements Identify Patients With Rapid or Slow Fibrosis - (DGNews)
    Head-to-Head Studies Identify Best Treatment Regimen for Hepatitis C - (DGNews)

    News archive

     Recent webcasts/CME - Hepatitis C
    • Improving the Standard of Care for HCV Management: Available and Emerging Strategies for Optimal Patient Outcomes
    • Improving Outcomes in Hepatitis C
    • Issues in the Care of HIV and Hepatitis C Virus-coinfected Patients: Antiretroviral Pharmacokinetics, Drug Interactions, and Liver Transplantation
      Cancer, Liver, Infections, Cardiovascular Disease, and other Biologic Agents
      Treating a Patient with RA and Hepatitis B or C

      Webcasts/CME archive

       Recent cases - Hepatitis C
        The Influence Of Hepatitis C Infection And Interferon-alpha Therapy On Thyrotropin Blocking And Stimulating Autoantibodies In Graves' Ophthalmopathy: A Case Report
        Pseudoleukocytosis Secondary to Hepatitis C-Associated Cryoglobulinemia: A Case Report
        Primary Central Nervous System Lymphoma Presenting as Bilateral Uveitis in an Immunocompetent HCV+ Patient: A Case Report
        Intra-Hepatic Splenosis as an Unexpected Cause of a Focal Liver Lesion in a Patient with Hepatitis C and Liver Cirrhosis: A Case Report
        Hepatitis Following Famotidine: A Case Report

        Cases archive
          




        my personal edition > hepatitis c > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Researchers Isolate Genes That Battle Hepatitis C Virus

          HAIFA, ISRAEL -- July 17, 2007 -- Joint research by Dr. Leonid Brodsky, of the Institute of Evolution of the University of Haifa, and Dr. Milton Taylor, of Indiana University, led to the discovery of a mathematical method which can identify which genes in our bodies conduct the battle against the various viruses that attack us. In their research, they identified 37 genes out of 22,000 possible genes which fight the hepatitis C virus.

          "When we know which genes are responsible for fighting the viruses which attack our liver, we will be able to look for the medications which will activate these genes most favorably," said Dr. Brodsky. The team conducted clinical trials, supported by the Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the US National Institutes of Health (NIH), which included 400 patients at eight different centers in the United States.

          The results will be published in the journal PLOS ONE.

          The hepatitis C virus, found mostly among many patients who have had a blood transfusion or who share needles, attacks the liver and in extreme cases can cause cancer of the liver. At present, there is one well know medication, interferon, used to treat the virus; however, while some patients respond to the treatment with interferon, others do not. In this research, the clinical study was combined with the mathematical model developed by Dr. Brodsky. The study identified 37 genes which are key for patient response to treatment.

          "In the specific case of hepatitis C, we have now isolated the genes that show which patients will respond to treatment. Until now, all patients received treatment for an extended period of time without knowing whether or not they would respond. In the future, we hope to find other medications that will be more effective in activating all of the 37 genes." summarized Dr. Brodsky.

          He further explained that this mathematical model is not limited to identifying the genes which fight viruses that attack the liver. It can also be applied further in the fields of medicine, biology and agriculture.


          SOURCE: University of Haifa




        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2010 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send